3Lazarowski A,Dupont J,Fernandez J,et al.99mTechnetium-SESTAMIBI uptake in malignant lymphomas Correlation with chemotherapy response[J].Lymphat Res Biol,2006;4(1):23-8.
4Cermik TF,Altiay G,Firat MF,et al.Assessment of Tc-99m sestamibi tumor tissue uptake under the influence of increased arterial oxygen saturation[J].Nucl Med Biol,2005;32(2):165-70.
5Zhou J,Higashi K,Ueda Y,et al.Expression of multidrug resistance protein and messenger RNA correlate with (99m) Tc-MIBI imaging in patients with lung cancer[J].J Nucl Med,2001;42(10):1476-83.
6Bagni B,Franceschetto A,Casolo A,et al.Scintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer[J].Eur J Nucl Med Mol Imaging,2003;30(10):1383-8.
7Nagamachi S,Jinnouchi S,Nabeshima K,et al.The correlation between 99mTc-MIBI uptake and MIBI as a nuclear proliferation marker in glioma:a comparative study with 201Tl[J].Neuroradiology,2001;43(12):1023-30.
8Choi WW,Lewis MM,Lawson D,et al.Angiogenic and lymphangiogenic microvessel density in breast carcinoma:correlation with clinicopathologic parameters and VEGF-family gene expression[J].Mod Pathol,2005;18(1):143-52.
9Miyoshi Y,Ando A,Takamura Y,et al.Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues[J].Int J Cancer,2002;97(1):129-32.
10Olcn E,Klind GH.Hyperthyroidism and thyroid cancer[J].Arch Pathol,1966,81:531.
